ExcelFin Acquisition Corp. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance sheets

In millions of USD, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Deferred offering costs
Current Assets:
Cash
Prepaid expenses
Total Current Assets
Cash held in trust
Non-current prepaid expenses
Income Tax Receivable
Deferred Tax Asset
Total Assets
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Accounts payable and accrued expenses
Excise tax payable
Income taxes payable
Franchise tax payable
Unrecognized tax benefit
Accrued offering costs
Accrued formation costs
Due to related parties
Working capital loan - Sponsor
Sponsor
Total working capital loan - Sponsor
Total Current Liabilities
Deferred underwriting compensation
Total liabilities
Common stock, subject to possible redemption (1,539,316 and 2,201,533 shares at redemption value as of June 30, 2024, and December 31, 2023, respectively)
Stockholders' deficit:
Class A common stock, $0.0001 par value, 200,000,000 authorized, 5,750,000 issued and outstanding as of June 30, 2024, and December 31, 2023 (excluding 1,539,316 and 2,201,533 shares subject to possible redemption as of June 30, 2024, and December 31, 2023, respectively)
Additional paid-in capital
Accumulated deficit
Total Stockholders' Deficit:
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit

Comments